4.5 Article

Analysis of intracellular doxorubicin and its metabolites by ultra-high-performance liquid chromatography

出版社

ELSEVIER
DOI: 10.1016/j.jchromb.2010.03.040

关键词

Ultra-high-performance liquid chromatography; Doxorubicin; Doxorubicinol

资金

  1. Japan Health Sciences Foundation
  2. Ministry of Health, Labour and Welfare (MHLW)
  3. Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [21790046]

向作者/读者索取更多资源

Doxorubicin, a highly effective anticancer drug, produces severe side effect such as cardiotoxicity, which is mainly caused by its metabolite, doxorubicinol While in vitro studies by measuring cellular concentration of doxorubicin have been reported, there have been no reports on measuring cellular concentration of the metabolites In this report, we developed a sensitive and high-throughput method for measuring cellular concentrations of doxorubicin and its metabolites by ultra-high-performance liquid chromatography The method achieved more than 96% recovery of doxorubicin and its metabolites from cell homogenates Using simple separation conditions, doxorubicin and its three main metabolites, and the internal standard, were separated within 3 min. The method has a limit of quantification of 174 pg (32 0 fmol) injected doxorubicin This high sensitivity enables the detection and intracellular quantification of doxorubicin and its metabolite, doxorubicinol, in cell homogenates, and its use will facilitate studies of the relationship between doxorubicin pharmacokinetics and therapeutic outcome (C) 2010 Elsevier BV All rights reserved

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据